Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 91 AL 105

Neuroinflammatory Responses Occur in Brain Lesions During Alzheimer's Disease: Postmortem Case Report

Belkhelfa M, Bekrar S, Rezaig L, Beder N, Touri F, Yousfi Y, Nabi H, Slimani A, Attal N, Belarbi A, Bessaha M, Touil-Boukoffa C.

J Alzheimers Dis. 2024;97(3):1323-1339. doi: 10.3233/JAD-230910.

Redox changes and cellular senescence in Alzheimer's disease

Yu N, Pasha M, Chua JJE.

Redox Biol. 2024 Apr;70:103048. doi: 10.1016/j.redox.2024.103048. Epub 2024 Jan 17.

Disentangling tau: One protein, many therapeutic approaches

Lane-Donovan C, Boxer AL.

Neurotherapeutics. 2024 Mar;21(2):e00321. doi: 10.1016/j.neurot.2024.e00321. Epub 2024 Jan 25.

Diversity of amyloid beta peptide actions

Mardanyan S, Sharoyan S, Antonyan A.

Rev Neurosci. 2024 Jan 29;35(4):387-398. doi: 10.1515/revneuro-2023-0100. Print 2024 Jun 25.

Converged avenues: depression and Alzheimer's disease- shared pathophysiology and novel therapeutics

Bajaj S, Mahesh R.

Mol Biol Rep. 2024 Jan 28;51(1):225. doi: 10.1007/s11033-023-09170-1.

Zebrafish Experimental Animal Models for AD: A Comprehensive Review

Sande R, Godad A, Doshi G.

Curr Rev Clin Exp Pharmacol. 2024;19(4):295-311. doi: 10.2174/0127724328279684240104094257.

Lessons Learned from Approval of Aducanumab for Alzheimer's Disease

Heidebrink JL, Paulson HL.

Annu Rev Med. 2024 Jan 29;75:99-111. doi: 10.1146/annurev-med-051022-043645.

Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management

Singh B, Day CM, Abdella S, Garg S.

J Control Release. 2024 Mar;367:402-424. doi: 10.1016/j.jconrel.2024.01.047. Epub 2024 Feb 1.

Mounting Evidence on the Relationship between Sleep and Alzheimer's Disease

De Gennaro L, Cordone S.

J Integr Neurosci. 2024 Jan 22;23(1):21. doi: 10.31083/j.jin2301021.

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease

Pathak C, Kabra UD.

Bioorg Chem. 2024 Mar;144:107152. doi: 10.1016/j.bioorg.2024.107152. Epub 2024 Jan 27.

Choriocapillaris and Retinal Vascular Alterations in Presymptomatic Alzheimer's Disease

Corradetti G, Oncel D, Kadomoto S, Arakaki X, Kloner RA, Sadun AA, Sadda SR, Chan JW.

Invest Ophthalmol Vis Sci. 2024 Jan 2;65(1):47. doi: 10.1167/iovs.65.1.47.

Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease

Guarnieri L, Bosco F, Leo A, Citraro R, Palma E, De Sarro G, Mollace V.

Ageing Res Rev. 2024 Mar;95:102210. doi: 10.1016/j.arr.2024.102210. Epub 2024 Feb 1.

The role of microRNAs in understanding sex-based differences in Alzheimer's disease

Llera-Oyola J, Carceller H, Andreu Z, Hidalgo MR, Soler-Sáez I, Gordillo F, Gómez-Cabañes B, Roson B, de la Iglesia-Vayá M, Mancuso R, Guerini FR, Mizokami A, García-García F.

Biol Sex Differ. 2024 Jan 31;15(1):13. doi: 10.1186/s13293-024-00588-1.

Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia

Liu R, Collier JM, Abdul-Rahman NH, Capuk O, Zhang Z, Begum G.

Aging Dis. 2024 Aug 1;15(4):1748-1770. doi: 10.14336/AD.2023.1201.

Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development

Ahmed H, Wang Y, Griffiths WJ, Levey AI, Pikuleva I, Liang SH, Haider A.

Brain. 2024 May 3;147(5):1622-1635. doi: 10.1093/brain/awae028.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias